{"id":"https://openalex.org/W4286296265","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.5000","title":"TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel\u2014Overall survival after median follow-up of 3 years (ANZUP 1603).","display_name":"TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel\u2014Overall survival after median follow-up of 3 years (ANZUP 1603).","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286296265","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.5000"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.5000","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.5000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.5000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063276705","display_name":"Michael S. Hofman","orcid":"https://orcid.org/0000-0001-8622-159X","observed_orcids":["https://orcid.org/0000-0001-8622-159X"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael S Hofman","raw_affiliation_strings":["Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057708677","display_name":"Louise Emmett","orcid":"https://orcid.org/0000-0002-4895-7384","observed_orcids":["https://orcid.org/0000-0002-4895-7384"]},"institutions":[{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Louise Emmett","raw_affiliation_strings":["Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia;","institution_ids":["https://openalex.org/I4210087284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064026461","display_name":"Shahneen Kaur Sandhu","orcid":"https://orcid.org/0000-0002-8660-4475","observed_orcids":["https://orcid.org/0000-0002-8660-4475"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shahneen Sandhu","raw_affiliation_strings":["Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029076956","display_name":"Amir Iravani","orcid":"https://orcid.org/0000-0002-1273-5835","observed_orcids":["https://orcid.org/0000-0002-1273-5835"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Amir Iravani","raw_affiliation_strings":["Peter MacCallum Cancer Center, Melbourne, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Center, Melbourne, Australia;","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085333470","display_name":"Anthony Michael Joshua","orcid":"https://orcid.org/0000-0001-5159-4580","observed_orcids":["https://orcid.org/0000-0001-5159-4580"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Anthony M. Joshua","raw_affiliation_strings":["Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada;","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018801649","display_name":"Jeffrey C.H. Goh","orcid":"https://orcid.org/0000-0002-1681-0484","observed_orcids":["https://orcid.org/0000-0002-1681-0484","https://orcid.org/0000-0003-3103-146X"]},"institutions":[{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jeffrey C. Goh","raw_affiliation_strings":["Department of Oncology, Royal Brisbane and Women\u2019s Hospital, Brisbane, QLD, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Royal Brisbane and Women\u2019s Hospital, Brisbane, QLD, Australia;","institution_ids":["https://openalex.org/I2799393793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041831251","display_name":"David A. Pattison","orcid":"https://orcid.org/0000-0001-9718-5598","observed_orcids":["https://orcid.org/0000-0001-9718-5598"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David A. Pattison","raw_affiliation_strings":["Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia;","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110503703","display_name":"Thean Hsiang Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Thean Hsiang Tan","raw_affiliation_strings":["Royal Adelaide Hospital, Adelaide, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Adelaide Hospital, Adelaide, Australia;","institution_ids":["https://openalex.org/I1320133117"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006815287","display_name":"Ian David Kirkwood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ian D. Kirkwood","raw_affiliation_strings":["Royal Adelaide Hospital, Adelaide, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Adelaide Hospital, Adelaide, Australia;","institution_ids":["https://openalex.org/I1320133117"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023881534","display_name":"Roslyn J. Francis","orcid":"https://orcid.org/0000-0002-6256-1351","observed_orcids":["https://orcid.org/0000-0002-6256-1351"]},"institutions":[{"id":"https://openalex.org/I2802220196","display_name":"Sir Charles Gairdner Hospital","ror":"https://ror.org/01hhqsm59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800882159","https://openalex.org/I2802220196","https://openalex.org/I4210133657","https://openalex.org/I4396570646"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Roslyn J. Francis","raw_affiliation_strings":["Sir Charles Gairdner Hospital, Perth, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sir Charles Gairdner Hospital, Perth, Australia;","institution_ids":["https://openalex.org/I2802220196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082406815","display_name":"Craig A. Gedye","orcid":"https://orcid.org/0000-0002-1629-4352","observed_orcids":["https://orcid.org/0000-0002-1629-4352"]},"institutions":[{"id":"https://openalex.org/I4210146798","display_name":"Calvary Mater Newcastle Hospital","ror":"https://ror.org/04kbz1397","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210146798"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Craig Gedye","raw_affiliation_strings":["Calvary Mater Newcastle, Waratah, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calvary Mater Newcastle, Waratah, NSW, Australia;","institution_ids":["https://openalex.org/I4210146798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021111124","display_name":"Natalie K. Rutherford","orcid":"https://orcid.org/0009-0000-2194-1617","observed_orcids":["https://orcid.org/0009-0000-2194-1617"]},"institutions":[{"id":"https://openalex.org/I4210146798","display_name":"Calvary Mater Newcastle Hospital","ror":"https://ror.org/04kbz1397","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210146798"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Natalie K. Rutherford","raw_affiliation_strings":["Calvary Mater Newcastle, Newcastle, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calvary Mater Newcastle, Newcastle, Australia;","institution_ids":["https://openalex.org/I4210146798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079624958","display_name":"Alison Yan Zhang","orcid":"https://orcid.org/0000-0002-1902-6863","observed_orcids":["https://orcid.org/0000-0002-1902-6863"]},"institutions":[{"id":"https://openalex.org/I4210093547","display_name":"Chris O\u2019Brien Lifehouse","ror":"https://ror.org/00qeks103","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210093547"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Alison Yan Zhang","raw_affiliation_strings":["Chris O'Brien Lifehouse, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chris O'Brien Lifehouse, Sydney, Australia;","institution_ids":["https://openalex.org/I4210093547"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000296685","display_name":"Margaret Mary McJannett","orcid":"https://orcid.org/0009-0000-1640-8068","observed_orcids":["https://orcid.org/0009-0000-1640-8068"]},"institutions":[{"id":"https://openalex.org/I4210158109","display_name":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group","ror":"https://ror.org/05jtex909","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210158109"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Margaret Mary McJannett","raw_affiliation_strings":["Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Camperdown, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Camperdown, NSW, Australia;","institution_ids":["https://openalex.org/I4210158109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061757629","display_name":"Martin R. Stockler","orcid":"https://orcid.org/0000-0003-3793-8724","observed_orcids":["https://orcid.org/0000-0003-3793-8724"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Martin R. Stockler","raw_affiliation_strings":["NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia;","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082622296","display_name":"Scott Williams","orcid":"https://orcid.org/0000-0002-1357-0884","observed_orcids":["https://orcid.org/0000-0002-1357-0884"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Scott Williams","raw_affiliation_strings":["Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024778370","display_name":"Andrew James Martin","orcid":"https://orcid.org/0000-0001-5804-2295","observed_orcids":["https://orcid.org/0000-0001-5804-2295"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I42131985","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70","country_code":"AU","type":"government","lineage":["https://openalex.org/I2801453606","https://openalex.org/I3149551504","https://openalex.org/I42131985"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew James Martin","raw_affiliation_strings":["NHMRC Clinical Trials Center, University of Sydney, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHMRC Clinical Trials Center, University of Sydney, Sydney, Australia;","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I42131985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064732405","display_name":"Ian D. Davis","orcid":"https://orcid.org/0000-0002-9066-8244","observed_orcids":["https://orcid.org/0000-0002-9066-8244"]},"institutions":[{"id":"https://openalex.org/I4210098920","display_name":"Eastern Health","ror":"https://ror.org/00vyyx863","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210098920"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ian D. Davis","raw_affiliation_strings":["Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia;","institution_ids":["https://openalex.org/I4210098920","https://openalex.org/I56590836"]}]},{"author_position":"last","author":{"id":null,"display_name":"The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":17,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"5000","last_page":"5000"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.763700008392334,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.763700008392334,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.1720000058412552,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.033900000154972076,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/177lu-lu-psma-617","display_name":"177Lu-PSMA-617","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cabazitaxel","display_name":"cabazitaxel","score":0.9909999966621399},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/docetaxel-refractory-disease","display_name":"docetaxel-refractory disease","score":0.8899999856948853},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9380000233650208},{"id":"https://openalex.org/keywords/psma-pet","display_name":"PSMA PET","score":0.6909999847412109},{"id":"https://openalex.org/keywords/psma-expression","display_name":"PSMA expression","score":0.6660000085830688},{"id":"https://openalex.org/keywords/radioligand-therapy","display_name":"radioligand therapy","score":0.6700000166893005},{"id":"https://openalex.org/keywords/restricted-mean-survival-time","display_name":"restricted mean survival time","score":0.8569999933242798},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.9690244197845459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9258366823196411},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.90496826171875},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.761725127696991},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5566551685333252},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5512441992759705},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5236722826957703},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.45010918378829956},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.432338148355484},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37835144996643066},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3710305094718933},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.36135971546173096},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3551860451698303},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.308071494102478},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.22254812717437744},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.15261703729629517}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.5000","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.5000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.5000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3134768182","https://openalex.org/W3030866164","https://openalex.org/W4389210100","https://openalex.org/W3160976744","https://openalex.org/W7133197517","https://openalex.org/W3153377661","https://openalex.org/W2981468397","https://openalex.org/W2921380741","https://openalex.org/W4408642899","https://openalex.org/W4391923390"],"abstract_inverted_index":{"5000":[0],"Background:":[1],"We":[2,53],"previously":[3],"reported":[4,231],"that":[5,102,333],"in":[6,26,210,232,252,256,266,270,276,336,341],"men":[7,311,351],"with":[8,63,83,100,110,130,207,306,315,352,357,371],"mCRPC":[9,94,353],"progressing":[10,95,354],"after":[11,96,195,200,242,355],"docetaxel":[12],"randomly":[13,127,183,278],"assigned":[14,21,128,184,234,237,248,261,279],"LuPSMA":[15,22,131,185,255,262,265,280,340,345],"vs.":[16,31,37,47,289],"cabazitaxel":[17,140,188,249,251,269,282,335],"(Lancet":[18],"2021),":[19,228],"those":[20,71,247,260,277],"has":[23],"significant":[24],"improvements":[25],"PSA":[27],"response":[28,34,362],"rate":[29,35],"(66%":[30],"37%),":[32],"RECIST":[33],"(49%":[36],"24%),":[38],"progression-free":[39],"survival":[40,61,158,273,374],"(HR":[41],"0.63),":[42],"less":[43],"G3-4":[44],"toxicities":[45],"(33%":[46],"53%)":[48],"and":[49,69,85,112,121,153,182,239,254,258,268,339,367],"better":[50],"patient-reported":[51,365],"outcomes.":[52],"now":[54],"report":[55],"the":[56,90,213],"secondary":[57],"endpoint":[58],"of":[59,75,117,119,191,212,221],"overall":[60],"(OS)":[62],"mature":[64],"follow-up,":[65],"for":[66,89,163,350,378,397],"trial":[67,92,400],"participants,":[68],"also":[70],"initially":[72],"excluded":[73,199,241,312,380],"because":[74],"low":[76,386],"PSMA-expression":[77,105],"or":[78,187,389],"discordant":[79],"disease":[80,118,391],"on":[81,381],"imaging":[82,99,314],"PSMA-PET":[84],"FDG-PET.":[86],"Methods:":[87],"Eligibility":[88],"TheraP":[91],"required":[93],"docetaxel,":[97,356],"PET":[98],"68Ga-PSMA-11":[101],"showed":[103],"high":[104],"(at":[106],"least":[107],"one":[108],"site":[109],"SUVmax\u226520),":[111],"18F-FDG":[113],"demonstrating":[114],"no":[115],"sites":[116],"FDG-positive":[120],"PSMA-negative":[122],"(discordant":[123],"disease).":[124],"Participants":[125],"were":[126,169,180,198,304],"treatment":[129,332],"(8.5-6GBq":[132],"every":[133,142],"6":[134,137,172],"weeks,":[135,144],"maximum":[136,145],"cycles)":[138],"vs":[139],"(20mg/m2":[141],"3":[143,176,342],"10":[146],"cycles).":[147],"OS":[148,369],"was":[149,230,274,287,323,375],"analyzed":[150],"by":[151,155,313],"intention-to-treat":[152],"summarized":[154],"restricted":[156],"mean":[157],"time":[159,220],"(RMST)":[160],"to":[161,175,284,297,320,329,384],"account":[162],"non-proportional":[164],"hazards.":[165],"Results:":[166],"291":[167,192],"patients":[168,379],"screened":[170],"from":[171],"Feb":[173],"2018":[174],"Sep":[177],"2019:":[178],"200":[179],"eligible":[181,396],"(99)":[186],"(101);":[189],"80":[190,214],"(27%)":[193],"registered":[194],"initial":[196],"eligibility":[197],"PSMA/FDG-PET(51":[201],"SUVmax":[202],"<":[203],"20,":[204],"29":[205,337],"discordant),":[206],"follow-up":[208,219],"available":[209],"61":[211,310],"(76%).":[215],"After":[216],"a":[217,347],"median":[218],"36":[222,285,321],"months":[223,286,322,325],"(data":[224],"cut-off":[225],"31":[226],"Dec":[227],"death":[229],"70/101":[233],"cabazitaxel,":[235],"77/99":[236],"LuPSMA,":[238],"55/61":[240],"PSMA/FDG-PET.":[243],"Subsequent":[244],"treatments":[245],"among":[246,259],"included":[250,263,334],"21,":[253],"20;":[257],"additional":[264,301],"5,":[267],"32.":[271],"Overall":[272],"similar":[275,368],"versus":[281],"(RMST":[283],"19.1":[288],"19.6":[290],"months,":[291],"difference":[292],"-0.5,":[293],"95%":[294],"CI":[295,327],"-3.7":[296],"+":[298],"2.7).":[299],"No":[300],"safety":[302],"signals":[303],"identified":[305],"longer":[307],"follow-up.":[308],"Among":[309],"PSMA/FDG-PET":[316,382],"before":[317],"randomisation,":[318],"RMST":[319],"11.0":[324],"(95%":[326],"9.0":[328],"13.1),":[330],"following":[331],"(48%)":[338],"(5%).":[343],"Conclusions:":[344],"is":[346],"suitable":[348],"option":[349],"lower":[358],"adverse":[359],"events,":[360],"higher":[361],"rates,":[363],"improved":[364],"outcomes,":[366],"compared":[370],"cabazitaxel.":[372],"Median":[373],"considerably":[376],"shorter":[377],"due":[383],"either":[385],"PSMA":[387],"expression":[388],"FDG-discordant":[390],"who":[392],"would":[393],"otherwise":[394],"be":[395],"LuPSMA.":[398],"Clinical":[399],"information:":[401],"NCT03392428.":[402]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":30},{"year":2022,"cited_by_count":15}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2022-07-21T00:00:00"}